Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.080
-0.020 (-1.82%)
Nov 3, 2025, 2:03 PM EST - Market open
Biofrontera Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$2.75
Upside
+154.63%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Maintains $7 → $2.75 | Strong Buy | Maintains | $7 → $2.75 | +154.63% | May 19, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +548.15% | Nov 15, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +548.15% | Aug 16, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,566.67% | Aug 31, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $140 → $18 | Strong Buy | Maintains | $140 → $18 | +1,566.67% | Jul 5, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +12,862.96% | May 15, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +12,862.96% | Mar 9, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $220 → $140 | Strong Buy | Reiterates | $220 → $140 | +12,862.96% | Jan 31, 2023 |
| Benchmark | Benchmark | Strong Buy Initiates $220 | Strong Buy | Initiates | $220 | +20,270.37% | Dec 15, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $400 | Strong Buy | Initiates | $400 | +36,937.04% | Nov 24, 2021 |